[1]

White MT, Sears CL. 2024. The microbial landscape of colorectal cancer. Nature Reviews Microbiology 22:240−254

doi: 10.1038/s41579-023-00973-4
[2]

Fernandez E, Wargo JA, Helmink BA. 2025. The microbiome and cancer: a translational science review. JAMA 333:2188−2196

doi: 10.1001/jama.2025.2191
[3]

Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, et al. 2018. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359:592−597

doi: 10.1126/science.aah3648
[4]

Janney A, Powrie F, Mann EH. 2020. Host–microbiota maladaptation in colorectal cancer. Nature 585:509−517

doi: 10.1038/s41586-020-2729-3
[5]

Jiang SS, Chen YX, Fang JY. 2026. Fusobacterium nucleatum: ecology, pathogenesis and clinical implications. Nature Reviews Microbiology 24:197−214

doi: 10.1038/s41579-025-01237-z
[6]

Chung L, Thiele Orberg E, Geis AL, Chan JL, Fu K, et al. 2018. Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells. Cell Host & Microbe 23:203−214

doi: 10.1016/j.chom.2018.01.007
[7]

Wu S, Lim KC, Huang J, Saidi RF, Sears CL. 1998. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proceedings of the National Academy of Sciences of the United States of America 95:14979−14984

doi: 10.1073/pnas.95.25.14979
[8]

Guo Y, Ouyang Z, He W, Qin Q, Zhang J, et al. 2026. Mechanistic diversity of Bacteroides fragilis toxins and neutralization with single domain antibody. Cell Chemical Biology 33:102−116.e6

doi: 10.1016/j.chembiol.2025.12.009
[9]

Tao L, Zhang J, Meraner P, Tovaglieri A, Wu X, et al. 2016. Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. Nature 538:350−355

doi: 10.1038/nature19799
[10]

Rathnayake SS, Erramilli SK, Kossiakoff AA, Vecchio AJ. 2024. Cryo-EM structures of Clostridium perfringens enterotoxin bound to its human receptor, claudin-4. Structure 32:1936−1951.e5

doi: 10.1016/j.str.2024.09.015
[11]

White MT, Wang K, Zhang H, Eckhard U, Hullahalli K, et al. 2026. A pro-carcinogenic bacterial toxin binds claudin-4 to cleave E-cadherin. Nature 654:504−512

doi: 10.1038/s41586-026-10375-0
[12]

Eckhard U, Ramírez-Larrota JS, Estevan-Morió E, Gomis-Rüth FX. 2026. The protease code of the bacterial gut microbiota: ecological regulation, barrier disruption, and rewiring host defense and signaling. Gut Microbes 18:2687149

doi: 10.1080/19490976.2026.2687149
[13]

Spiga L, Fansler RT, Wu Y, Grote A, Langford-Butler M, et al. 2026. An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut. Cell 189:3968−3990.e38

doi: 10.1016/j.cell.2026.04.012
[14]

Abramson J, Adler J, Dunger J, Evans R, Green T, et al. 2024. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630:493−500

doi: 10.1038/s41586-024-07487-w
[15]

Vandenbroucke RE, Libert C. 2014. Is there new hope for therapeutic matrix metalloproteinase inhibition? Nature Reviews Drug Discovery 13:904−927

doi: 10.1038/nrd4390
[16]

Günzel D, Yu AS. 2013. Claudins and the modulation of tight junction permeability. Physiological Reviews 93:525−569

doi: 10.1152/physrev.00019.2012
[17]

Wray C, Mao Y, Pan J, Chandrasena A, Piasta F, et al. 2009. Claudin-4 augments alveolar epithelial barrier function and is induced in acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 297:L219−L227

doi: 10.1152/ajplung.00043.2009
[18]

Kage H, Flodby P, Gao D, Kim YH, Marconett CN, et al. 2014. Claudin 4 knockout mice: normal physiological phenotype with increased susceptibility to lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology 307:L524−L536

doi: 10.1152/ajplung.00077.2014
[19]

Rokkam D, LaFemina MJ, Lee JW, Matthay MA, Frank JA. 2011. Claudin-4 levels are associated with intact alveolar fluid clearance in human lungs. The American Journal of Pathology 179:1081−1087

doi: 10.1016/j.ajpath.2011.05.017